Putnam Investments LLC Provention Bio, Inc. Transaction History

Putnam Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 22, 2023	BUY	$6.7 - $24.21 $107,910 - $389,926	16,106 New	16,106 $388,000
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $1.42 Million - $2.33 Million	-211,006 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $643,419 - $1.24 Million	63,579 Added 43.13%	211,006 $2.22 Million
Q4 2020 Feb 16, 2021	BUY	$11.79 - $18.94 $14,749 - $23,693	1,251 Added 0.86%	147,427 $2.5 Million
Q3 2020 Nov 16, 2020	BUY	$10.34 - $15.2 $96,037 - $141,177	9,288 Added 6.79%	146,176 $1.88 Million
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $1.07 Million - $2.33 Million	136,888 New	136,888 $1.93 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.